Effect of Cichorium intybus L. on the expression of hepatic NF-κB and IKKβ and serum TNF-α in STZ-and STZ+ niacinamide-induced diabetes in rats

Diabetology and Metabolic Syndrome

Volumn 8, Issue 1, 2016, Pages

  Rezagholizadeh, Lotfollah ^a   Pourfarjam, Yasin ^a   Nowrouzi, Azin ^a   Nakhjavani, Manuchehr ^b   Meysamie, Alipasha ^a   Ziamajidi, Nasrin ^c   Nowrouzi, Peyman S ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chicory; Diabetes type 2; IKK ; Inflammatory cytokines; NF B; TNF

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; CICHORIUM INTYBUS EXTRACT; GLUCOSE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MESSENGER RNA; METFORMIN; NICOTINAMIDE; PLANT EXTRACT; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHICORY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA BINDING; GENE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIVER TISSUE; MALE; NONHUMAN; P65 GENE; PLANT SEED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

EID: 85027949211     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/s13098-016-0128-6     Document Type: Article

References (51)

1. Garcia C, Feve B, Ferre P, Halimi S, Baizri H, Bordier L, et al. Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes Metab. 2010;36(5):327-38.
2. Vu BG, Stach CS, Kulhankova K, Salgado-Pabon W, Klingelhutz AJ, Schlievert PM. Chronic superantigen exposure induces systemic inflammation, elevated bloodstream endotoxin, and abnormal glucose tolerance in rabbits: possible role in diabetes. MBio. 2015;6(2):e02554.doi:10.1128/mBio.02554-14.
3. Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab. 2012;38(3):183-91.
4. Manning PJ, Sutherland WH, Hendry G, de Jong SA, McGrath M, Williams SM. Changes in circulating postprandial proinflammatory cytokine concentrations in diet-controlled type 2 diabetes and the effect of ingested fat. Diabetes Care. 2004;27(10):2509-11.
5. Chen F. Is NF-kappaB a culprit in type 2 diabetes? Biochem Biophys Res Commun. 2005;332(1):1-3.
6. Csehi S-B, Mathieu S, Seifert U, Lange A, Zweyer M, Wernig A, et al. Tumor necrosis factor (TNF) interferes with insulin signaling through the p55 TNF receptor death domain. Biochem Biophys Res Commun. 2005;329(1):397-405.
7. Skolnik EY, Marcusohn J. Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus. Cytokine Growth F R. 1996;7(2):161-73.
8. Umesalma S, Sudhandiran G. Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1, 2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin Pharmacol Toxicol. 2010;107(2):650-5.
9. Leiherer A, Mundlein A, Drexel H. Phytochemicals and their impact on adipose tissue inflammation and diabetes. Vasc Pharmacol. 2013;58:3-20.
10. Ahmed B, Khan S, Masood MH, Siddique AH. Anti-hepatotoxic activity of cichotyboside, a sesquiterpene glycoside from the seeds of Cichorium intybus. J Asian Nat Prod Res. 2008;10(3):223-31.
11. Azay-Milhau J, Ferrare K, Leroy J, Aubaterre J, Tournier M, Lajoix A-D, et al. Antihyperglycemic effect of a natural chicoric acid extract of chicory (Cichorium intybus L.): a comparative in vitro study with the effects of caffeic and ferulic acids. J Ethnopharmacol. 2013;150(2):755-60.
12. Keshk WA, Noeman SA. Impact of chicory-supplemented diet on HMG-CoA reductase, acetyl-CoA carboxylase, visfatin and anti-oxidant status in triton WR-1339-induced hyperlipidemia. J Food Biochem. 2015;39(2):164-72.
13. Lin W, Liu C, Yang H, Wang W, Ling W, Wang D. Chicory, a typical vegetable in mediterranean diet, exerts a therapeutic role in established atherosclerosis in apolipoprotein E-deficient mice. Mol Nutr Food Res. 2015;59(9):1-11.
14. Matvieieva NA, Kudryavets Iu I, Likhova AA, Shakhovskji AM, Bezdenezhnykh NA, Kvasko E. Antiviral activity of extracts of transgenic cichory and lettuce plants with the human interferon alpha-2b gene. Cytol Genet. 2012;46:285-90.
15. Saggu S, Sakeran MI, Zidan N, Tousson E, Mohan A, Rehman H. Ameliorating effect of chicory (Chichorium intybus L.) fruit extract against 4-tertoctylphenol induced liver injury and oxidative stress in male rats. Food Chem Toxicol. 2014;72:138-46.
16. Xiao H, Xie G, Wang J, Hou X, Wang X, Wu W, et al. Chicoric acid prevents obesity by attenuating hepatic steatosis, inflammation and oxidative stress in high-fat diet-fed mice. Food Res Int. 2013;54(1):345-53.
17. Abbas ZK, Saggu S, Sakeran MI, Zidan N, Rehman H, Ansari AA. Phytochemical, antioxidant and mineral composition of hydroalcoholic extract of chicory (Cichorium intybus L.) leaves. Saudi. J Biol Sci. 2015;22(3):322-6.
18. Nishimura M, Ohkawara T, Kanayama T, Kitagawa K, Nishimura H, Nishihira J. Effects of the extract from roasted chicory (Cichorium intybus L.) root containing inulin-type fructans on blood glucose, lipid metabolism, and fecal properties. J Tradit Complement Med. 2015;5(3):161-7.
19. Olsen NJ, Branch VK, Jonnala G, Seskar M, Cooper M. Phase 1, placebocontrolled, dose escalation trial of chicory root extract in patients with osteoarthritis of the hip or knee. BMC Musculoskel Dis. 2010;11:156.
20. Schumacher E, Vigh E, Molnar V, Kenyeres P, Feher G, Kesmarky G, et al. Thrombosis preventive potential of chicory coffee consumption: a clinical study. Phytother Res. 2011;25(5):744-8.
21. Ghamarian A, Abdollahi M, Su X, Amiri A, Ahadi A, Nowrouzi A. Effect of chicory seed extract on glucose tolerance test (GTT) and metabolic profile in early and late stage diabetic rats. Daru. 2012;20(1):56.
22. Viollet B, Foretz M. Revisiting the mechanisms of metformin action in the liver. Ann Endocrinol (Paris). 2013;74(2):123-9.
23. Yeomans ND. Aspirin: old drug, new uses and challenges. J Gastroen Hepatol. 2011;26(3):426-31.
24. Law EH, Simpson SH. Aspirin use rates in diabetes: a systematic review cross-sectional study. Can J Diabetes. 2010;34(3):211-7.
25. Williamson RT. On the treatment of glycosuria and diabetes mellitus with sodium salicylate. Brit Med J. 1901;1(2100):760-2.
26. Foretz M, Hebrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G, et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010;120(7):2355-69.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
28. Pushparaj PN, Low HK, Manikandan J, Tan BKH, Tan CH. Anti-diabetic effects of Cichorium intybus in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2007;111(2):430-4.
29. Sun X, Han F, Yi J, Han L, Wang B. Effect of aspirin on the expression of hepatocyte NF-kappaB and serum TNF-alpha in streptozotocin-induced type 2 diabetic rats. J Korean Med Sci. 2011;26(6):765-70.
30. Irondi EA, Oboh G, Akindahunsi AA, Boligon AA, Athayde ML. Phenolics composition and antidiabetic property of Brachystegia eurycoma seed flour in high-fat diet, low-dose streptozotocin-induced type 2 diabetes in rats. Asian Pac J Trop Dis. 2015;5(Supplement 1):S159-65.
31. Chou TW, Ma CY, Cheng HH, Chen YY, Lai MH. A rice bran oil diet improves lipid abnormalities and suppress hyperinsulinemic responses in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Clin Biochem Nutr. 2009;45(1):29-36.
32. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998;47(2):224-9.
33. Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol. 2002;8(1):81-100.
34. Chu Y-F, Chen Y, Black RM, Brown PH, Lyle BJ, Liu RH, et al. Type 2 diabetes-related bioactivities of coffee: assessment of antioxidant activity, NF-κB inhibition, and stimulation of glucose uptake. Food Chem. 2011;124(3):914-20.
35. Gupta SC, Sundaram C, Reuter S, Aggarwal BB. Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta. 2010;1799(10-12):775-87.
36. Ma Q, Kinneer K, Ye J, Chen BJ. Inhibition of nuclear factor kappaB by phenolic antioxidants: interplay between antioxidant signaling and inflammatory cytokine expression. Mol Pharmacol. 2003;64(2):211-9.
37. Patel S, Santani D. Role of NF-kappa B in the pathogenesis of diabetes and its associated complications. Pharmacol Rep. 2009;61(4):595-603.
38. Nowrouzi A, Pourfarjam Y, Amiri A. Cichorium intybus L. (CI) as an insulin sensitizer. Diabetes. 2013;62(Suppl 1):A304.
39. Rizvi W, Fayazuddin M, Shariq S, Singh O, Moin S, Akhtar K, et al. Antiinflammatory activity of roots of Cichorium intybus due to its inhibitory effect on various cytokines and antioxidant activity. Anc Sci Life. 2014;34(1):44-9.
40. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2000;11(6):212-7.
41. Sun SC. Non-canonical NF-kappaB signaling pathway. Cell Res. 2011;21(1):71-85.
42. Kabuta T, Hakuno F, Cho Y, Yamanaka D, Chida K, Asano T, et al. Insulin receptor substrate-3, interacting with Bcl-3, enhances p50 NF-kappaB activity. Biochem Biophys Res Commun. 2010;394(3):697-702.
43. Cavin C, Delannoy M, Malnoe A, Debefve E, Touche A, Courtois D, et al. Inhibition of the expression and activity of cyclooxygenase-2 by chicory extract. Biochem Biophys Res Commun. 2005;327(3):742-9.
44. Ziamajidi N, Khaghani S, Hassanzadeh G, Vardasbi S, Ahmadian S, Nowrouzi A, et al. Amelioration by chicory seed extract of diabetes-and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARalpha and SREBP-1. Food Chem Toxicol. 2013;58:198-209.
45. Dragomir E, Tircol M, Manduteanu I, Voinea M, Simionescu M. Aspirin and PPAR-α activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells. Vasc Pharmacol. 2006;44(6):440-9.
46. Yuan H, Li L, Zheng W, Wan J, Ge P, Li H, et al. Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice. Int Immunopharmacol. 2012;12(4):682-8.
47. Arai M, Uchiba M, Komura H, Mizuochi Y, Harada N, Okajima K. Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. J Pharmacol Exp Ther. 2010;334(1):206-13.
48. Yuen KH, Peh KK. Simple high-performance liquid chromatographic method for the determination of metformin in human plasma. J Chromatogr B. 1998;710(1-2):243-6.
49. Buse JB, DeFronzo RA, Rosenstock J, Kim T, Burns C, Skare S, et al. The primary glucose-lowering effect of metformin resides in the Gut, not the circulation. results from short-term Pharmacokinetic and 12-week doseranging studies. Diabetes Care. 2015.doi:10.2337/dc15-0488.
50. Tousch D, Lajoix AD, Hosy E, Azay-Milhau J, Ferrare K, Jahannault C, et al. Chicoric acid, a new compound able to enhance insulin release and glucose uptake. Biochem Biophys Res Commun. 2008;377(1):131-5.
51. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, et al. Nutrition recommendations and interventions for diabetes-2006: a position statement of the American Diabetes Association. Diabetes Care. 2006;29(9):2140-57.